KRAS and breast cancer: Once activated in the luminal epithelium, the expression of exogenous or endogenous mutant KRAS occurs in a differentiation-independent manner in both mammary cancer models, which is a prerequisite to uncover the full extent of cellular plasticity that is mediated by the oncogenic driver.